| 产品详情 |
| Edit |   |
| Product Name | Abiraterone-d4 |
| Description | Labeled Abiraterone. A steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| Size | 1mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4; |
| Gene, Accession, CAS # | n/a |
| Catalog # | 1017 |
| Price | |
| Order / More Info | Abiraterone-d4 from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|